Patel Sujal M

CEO, President, and Secretary, Director, 10% OwnerNautilus Biotechnology, Inc. (NAUT) · full profile →Form 4 · filed Mar 11, 2024
Net Buying
Open-Market Buys
$41K
Open-Market Sells
$0
Net Open-Market Flow
$41K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 11, 2024Buy(P)12K$2.84$34K10.1M
Mar 8, 2024Buy(P)2K$2.99$7K10.1M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001808805-24-000026) within minutes of acceptance. Every field above traces to the original document. Verify it directly: